Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Retinoblastoma: from bench to bedside.

Richard L Hurwitz1, Patricia Chévez-Barrios, Milton Boniuk

  • 1Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA. rhurwitz@bcm.tmc.edu

Expert Reviews in Molecular Medicine
|February 28, 2004
PubMed
Summary

Retinoblastoma (Rb), a childhood eye cancer caused by RB1 gene mutations, can be heritable or sporadic. While metastatic Rb lacks effective treatment, early-stage cases are curable, with research focusing on eye-saving strategies and animal models.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Updates in mycobacterial keratitis diagnosis and treatment.

Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society·2026
Same author

Acral lentiginous melanoma metastases to the vitreous masquerading as uveitis: A case report.

American journal of ophthalmology case reports·2026
Same author

Growing teratoma syndrome of the ovary: a case series.

Journal of medical case reports·2026
Same author

Erratum: Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Androgen activity in the male embryonic hindbrain drives lethal PFA ependymoma.

Nature·2026
Same author

Immunotherapy approaches for the treatment of relapsed or progressive medulloblastoma.

Journal of neuro-oncology·2026

Area of Science:

  • Pediatric Oncology
  • Ophthalmology
  • Cancer Genetics

Background:

  • Retinoblastoma (Rb) is the most frequent primary ocular malignancy in children.
  • It arises from mutations in the RB1 gene, with 40% of cases being heritable (constitutional) and 60% sporadic.
  • Rb predominantly affects young children and can metastasize to extraocular sites.

Purpose of the Study:

  • To summarize the current understanding of Retinoblastoma (Rb).
  • To discuss the genetic basis, clinical presentation, and treatment landscape of Rb.
  • To review the utility of animal models in Rb research.

Main Methods:

  • Literature review of Retinoblastoma (Rb) pathogenesis, clinical features, and therapeutic approaches.
  • Analysis of genetic factors, including constitutional and sporadic RB1 mutations.

Related Experiment Videos

  • Evaluation of xenograft and transgenic animal models for studying Rb.

    • Main Results:

    • Rb is primarily caused by RB1 gene mutations, leading to heritable or sporadic forms.
    • Non-metastatic Rb is curable via enucleation, with emerging focus on eye salvage.
    • Existing animal models offer distinct advantages and limitations for Rb research.

    Conclusions:

    • Understanding Rb's genetic underpinnings is crucial for diagnosis and treatment.
    • Advancements in treatment aim to preserve the affected eye.
    • Animal models are essential tools for dissecting Rb mechanisms and testing novel therapies.